E-Paper
Bharat Biotech commences direct supply of 'Covaxin' to 14 states
Bharat Biotech, the Hyderabad-based firm has started supplying its Covid-19 treatment vaccine to the states based on the allocations received by the central government.
Bharat Biotech has commenced direct supply of its Covid-19 vaccine 'Covaxin' to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company's Joint Managing Director Suchitra Ella.
The Hyderabad-based firm has started supplying its Covid-19 treatment vaccine to the states based on the allocations received by the central government.
"Bharat Biotech confirms direct supplies of COVAXIN to the following state govt's since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24x7," Ella tweeted.
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
On April 29, Bharat Biotech announced a cut in the price of 'Covaxin' for states to ₹400 per dose from the earlier ₹600 per dose.
This followed widespread criticism of its pricing policy as it sold Covaxin to the central government at ₹150 per dose.
India has announced expansion of its Covid-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.
